Massachusetts General Hospital: Respiratory Distress Syndrome trials

The registry lists 11 Respiratory Distress Syndrome studies with Massachusetts General Hospital as lead sponsor. 1 are open to participants now and 4 have results posted.

Phase 2 2Phase 3 2No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Vascular ARDS Recruitment After Inhaled Nitric OxideRecruitingNCT05801224Not applicable
• Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19TerminatedNCT04305457Phase 2Results posted
• Acetaminophen and Ascorbate in Sepsis: Targeted Therapy to Enhance RecoveryCompletedNCT04291508Phase 2Results posted
• Vitamin D to Improve Outcomes by Leveraging Early TreatmentCompletedNCT03096314Phase 3Results posted
• Reevaluation Of Systemic Early Neuromuscular BlockadeCompletedNCT02509078Phase 3Results posted
• Comparing Different Delivery Systems of Continuous Positive Airway Pressure in NeonatesWithdrawnNCT06038565Not applicable
• Non-Invasive Monitoring of Respiratory Function in Spontaneously Breathing Patients With COVID-19 InfectionTerminatedNCT04356443
• Open Lung Strategy, Gas Distribution and Right Heart Function in ARDS PatientsTerminatedNCT03202641Not applicable
• Neurally Adjusted Ventilatory Assist (NAVA) Study in Adults With Acute Respiratory FailureCompletedNCT01730794Not applicable
• ARDSnet Protocol vs. Open Lung Approach in ARDSCompletedNCT00431158Not applicable
• Molecular Epidemiology of Acute Respiratory Distress Syndrome (ARDS)Active, not recruitingNCT00006496